Literature DB >> 11112455

Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells.

M Kawakami1, S Iwasaki, K Sato, M Takahashi.   

Abstract

Erythropoietin (EPO) and EPO receptor (EPO-R) are expressed in the brain but their neuronal functions are not yet clarified. The effects of EPO on neurosecretion were studied using clonal rat pheochromocytoma PC12 cells. EPO suppressed Ca(2+)-induced dopamine release from PC12 cells in a concentration- and time-dependent manner. Inhibition was also produced by an EPO mimetic peptide 1 (EMP1), a small synthetic peptide agonist of EPO-R, but not by its inactive analogue in which Cys residues were substituted with Ser. Inhibition was abolished by genistein but not by genistin. EPO and EMP1 induced autophosphorylation of Janus kinase 2 (JAK 2), a tyrosine kinase that associates with EPO-R, and dephosphorylation of GAP-43 in a tyrosine kinase-dependent fashion. These results suggest that EPO suppresses neurotransmitter release through activation of EPO-R linked to JAK2. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112455     DOI: 10.1006/bbrc.2000.3926

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping.

Authors:  Stephana Carelli; Giorgio Ghilardi; Paola Bianciardi; Elisa Latorre; Federico Rubino; Marina Bissi; Anna Maria Di Giulio; Michele Samaja; Alfredo Gorio
Journal:  Neurol Sci       Date:  2015-10-22       Impact factor: 3.307

2.  Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments.

Authors:  Anurima Majumder; Annet Kirabo; Kanchana Karrupiah; Shigeharu Tsuda; Jennifer Caldwell-Busby; Arturo J Cardounel; György M Keseru; Peter P Sayeski
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

3.  Erythropoietin neuroprotection with traumatic brain injury.

Authors:  Lucido L Ponce; Jovany Cruz Navarro; Osama Ahmed; Claudia S Robertson
Journal:  Pathophysiology       Date:  2012-03-14

Review 4.  Epo and other hematopoietic factors.

Authors:  Sandra Juul; Ursula Felderhoff-Mueser
Journal:  Semin Fetal Neonatal Med       Date:  2007-02-23       Impact factor: 3.926

5.  Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.

Authors:  Murat Celik; Necati Gökmen; Serhat Erbayraktar; Mustafa Akhisaroglu; Selman Konakc; Cagnur Ulukus; Sermin Genc; Kursad Genc; Emel Sagiroglu; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  Erythropoietin negatively regulates pituitary ACTH secretion.

Authors:  Soumyadeep Dey; Tyler Scullen; Constance Tom Noguchi
Journal:  Brain Res       Date:  2015-03-09       Impact factor: 3.252

7.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

Review 8.  Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?

Authors:  Roberto Latini; Michael Brines; Fabio Fiordaliso
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

Review 9.  Erythropoietin modulates the neural control of hypoxic ventilation.

Authors:  Max Gassmann; Jorge Soliz
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

Review 10.  Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.

Authors:  Anna-Leena Sirén; Theresa Fasshauer; Claudia Bartels; Hannelore Ehrenreich
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.